(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

MACSXPRESS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

MACSXPRESS

ST13

US500000079125211

Classe

1, 5

Pedido

79125211

Registro

4460561

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

53

Atualização mais recente

13/09/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5

Data de depósito

11/09/2012

Data de registro

07/01/2014

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

04/09/2024

Última transação

13/09/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

706

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

30

Localização do titular

Bergisch Gladbach, DE

Examinador

CLYBURN, DIONNE

Localização atual

Historical data usage

Titulares e representantes

Titulares

Miltenyi Biotec B.V. & Co. KG
Miltenyi Biotec GmbH

Representantes

Peter S. Sloane Leason Ellis LLP

Classificação técnica

Classes Nice

Classe 1Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemicals used in industry and science; reagentsmediacompounds and supplements for the preparation of mediaall for use in industry and science and for medical laboratory use contained in this class; reagents for processingseparationisolationenrichmentdepletiondetectionscreeninganalysis and enumeration of materialin particularof chemicals and biological materialmagnetic beads reagentsantibody reagentsother than for medical or veterinary use; buffers and reagents for use with laboratory equipmentin particularseparatorsanalyzersreactors and imaging equipment; reagents for processing biological materialin particulartissuebone marrowcellsblood and its componentsother than for medical or veterinary use; diagnostic reagents and preparations for research use; culture mediacell growth mediacryopreservation mediacontrast mediacontrast media for in-vivo imagingall for research use; reagents for use in biotechnologybiological processing and in the biotechnology industry

Classe 5

Pharmaceutical and veterinary preparationsdiagnostic preparationsagentsreagentssubstances and contrast media for medical usecontrasting agents for use in MRI imaging and in-vivo labeling of cell types for medical or veterinary purposesdiagnostic preparations for in-vivo imaging for medical or veterinary purposes; pharmaceutical preparationspharmaceutical preparations for extracorporeal plasma therapyimmunological preparationspreparations for apheresissolutions for extracorporeal plasma therapypreparations for anticoagulation; pharmaceutical preparations for the treatment of immunologicalrheologicalmetaboliclipoproteincancer disorders and therapeutic plasma exchange; reagentsmediacompounds and supplements for the preparation of mediaall for medical or veterinary use; reagents for processingseparationisolationenrichmentdepletiondetectionscreeninganalysis and enumeration of materialin particularof biological materialmagnetic beads reagentsantibody reagentsall for medical or veterinary use; buffers and reagents for medical or veterinary usefor use with medical equipmentin particularseparatorsanalyzersreactors and imaging equipment; reagents for processing biological materialin particulartissuebone marrowcellsblood and its componentsall for medical or veterinary use; diagnostic reagents and preparations for medical and veterinary use; culture mediacell growth mediacryopreservation mediacontrast mediacontrast media for in-vivo imagingall for medical or veterinary use; diagnostic reagents and preparations for medical use

Publicações

Histórico de despachos e eventos da marca no USPTO.

53 publicações encontradas

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

12/09/2025

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

20/08/2025

INPC

INVALIDATION PROCESSED

20/08/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

15/07/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

15/07/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

15/07/2025

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

04/05/2025

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

04/09/2024

71AG

REGISTERED-SEC.71 ACCEPTED

04/09/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/09/2024

ES71

TEAS SECTION 71 RECEIVED

29/11/2023

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

07/01/2023

RNWL

INTERNATIONAL REGISTRATION RENEWED

06/10/2022

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

28/08/2020

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

28/08/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

21/07/2020

ES75

TEAS SECTION 71 & 15 RECEIVED

26/05/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

20/02/2020

CHLD

CHANGE OF OWNER RECEIVED FROM IB

05/12/2019

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

07/01/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

28/04/2016

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/11/2014

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

20/06/2014

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/06/2014

FIMP

FINAL DISPOSITION PROCESSED

04/06/2014

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/04/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

07/01/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

22/10/2013

PUBO

PUBLISHED FOR OPPOSITION

22/10/2013

GPNX

NOTIFICATION PROCESSED BY IB

21/10/2013

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/10/2013

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/10/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/10/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

16/09/2013

ALIE

ASSIGNED TO LIE

13/09/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/09/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

13/08/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

13/08/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

13/08/2013

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

24/07/2013

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

24/07/2013

RFNP

REFUSAL PROCESSED BY IB

25/03/2013

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/03/2013

RFRR

REFUSAL PROCESSED BY MPU

01/03/2013

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/03/2013

CNRT

NON-FINAL ACTION WRITTEN

28/02/2013

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

27/02/2013

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

27/02/2013

CNRT

NON-FINAL ACTION WRITTEN

26/02/2013

MAFR

APPLICATION FILING RECEIPT MAILED

26/02/2013

DOCK

ASSIGNED TO EXAMINER

20/02/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

20/02/2013

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

15/02/2013

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace MACSXPRESS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.